Literature DB >> 33078561

Ethnic Disparities in the Diagnosis of Autism in Southern Israel.

Orly Kerub1,2, Eric J Haas2, Gal Meiri3, Natalya Bilenko2,4, Hagit Flusser5, Analya Michaelovski5, Ilan Dinstein6,7, Nadav Davidovitch1, Idan Menashe4,7.   

Abstract

The prevalence of autism spectrum disorder (ASD) is continuously rising worldwide, with remarkable differences in ASD rates being reported across ethnic and socioeconomic groups. We conducted a prospective cohort study to identify the reasons for differences in ASD rates between the Bedouin and Jewish populations in southern Israel. Screening, referral, and diagnosis of toddlers aged 16-36 months were compared between Bedouin and Jewish populations. ASD screening was conducted at 35 randomly selected mother and child health centers (MCHCs) by trained nurses using the Modified Checklist for Autism in Toddlers with follow-up (M-CHAT/F) instrument. Toddlers screened positive at the MCHCs were monitored throughout the referral and diagnosis process at a single medical center until a diagnosis was determined by a physician specialist using DSM-5 criteria. The study cohort comprised 3,343 toddlers (996 Jewish and 2,347 Bedouin). Bedouin toddlers, compared to Jewish toddlers, were less likely to screen positive with M-CHAT/F (3.0% vs. 3.9%; P = 0.165), were significantly less likely to begin the hospital diagnosis process (HR = 0.38, 95% CI: 0.14-1.08; P = 0.068), and had a higher rates of loss-to-follow-up during the hospital diagnosis process (42.9% vs. 15.6%, respectively; P = 0.001). The results suggest that ethnic-specific barriers in the diagnosis process of ASD contribute to under-diagnosis of ASD in the Bedouin population. Facilitating the diagnosis process for Bedouin families will help to identify more children with ASD at earlier ages and consequently close the ethnic gap in ASD rates. LAY
SUMMARY: We followed Bedouin and Jewish toddlers aged 16-36 months from southern Israel through their autism spectrum disorder (ASD) screening referral and diagnosis to identify the reasons for the differences in ASD prevalence between these ethnic groups. Jewish and Bedouin toddlers were equally identified in the ASD screening. However, Bedouin toddlers were less likely to complete the diagnosis process due to higher rates of loss-to-follow-up and slower diagnosis process. Facilitating ASD diagnosis for the Bedouin population will help identifying more toddlers with ASD.
© 2020 International Society for Autism Research and Wiley Periodicals LLC.

Entities:  

Keywords:  access to healthcare; autism diagnosis; autism spectrum disorder; ethnic disparities

Mesh:

Year:  2020        PMID: 33078561     DOI: 10.1002/aur.2421

Source DB:  PubMed          Journal:  Autism Res        ISSN: 1939-3806            Impact factor:   5.216


  4 in total

1.  The Importance of Language Delays as an Early Indicator of Subsequent ASD Diagnosis in Public Healthcare Settings.

Authors:  Tanya Nitzan; Judah Koller; Michal Ilan; Michal Faroy; Analya Michaelovski; Idan Menashe; Gal Meiri; Ilan Dinstein
Journal:  J Autism Dev Disord       Date:  2022-10-12

2.  Early diagnosis of autism in the community is associated with marked improvement in social symptoms within 1-2 years.

Authors:  Nitzan Gabbay-Dizdar; Michal Ilan; Gal Meiri; Michal Faroy; Analya Michaelovski; Hagit Flusser; Idan Menashe; Judah Koller; Ditza A Zachor; Ilan Dinstein
Journal:  Autism       Date:  2021-10-08

3.  Serum Vitamin D, Folate and Fatty Acid Levels in Children with Autism Spectrum Disorders: A Systematic Review and Meta-Analysis.

Authors:  Maria Carmen Gallardo-Carrasco; José Antonio Jiménez-Barbero; María Del Mar Bravo-Pastor; David Martin-Castillo; María Sánchez-Muñoz
Journal:  J Autism Dev Disord       Date:  2021-11-03

4.  Diagnostic Yield and Economic Implications of Whole-Exome Sequencing for ASD Diagnosis in Israel.

Authors:  Rotem Tal-Ben Ishay; Apurba Shil; Shirley Solomon; Noa Sadigurschi; Hadeel Abu-Kaf; Gal Meiri; Hagit Flusser; Analya Michaelovski; Ilan Dinstein; Hava Golan; Nadav Davidovitch; Idan Menashe
Journal:  Genes (Basel)       Date:  2021-12-23       Impact factor: 4.096

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.